We read with interest the letter to the editor by Wan et al 1 in which the interphase FISH (iFISH) patterns of a CML child showing an infrequent BCR/ABL translocation involving both chromosomes 9 and 22 is reported. The iFISH pattern observed consisted of one red, two green and one fusion (1R2G1F) signals once the BCR/ABL dual-color dual fusion (D-FISH) (Vysis Inc., Downer's Grove, IL, USA) probe was applied, and one red, one green and one fusion (1R1G1F) fluorescence dots with the BCR/ ABL ES (Vysis) probe coincident with what we recently described for CML patients with cryptic insertion of BCR in 9q34. 2 Despite the observation of a normal karyotype, the presence of the BCR/ABL gene fusion on chromosome 9 was confirmed by FISH on metaphase chromosomes, using the two mentioned probes plus a third BCR/ABL dual-color signal fusion (S-FISH) probe (Vysis). 1 In an updated series of 182 CML patients, we have found 15 cases (8%) showing similar patterns with the ES probe: one red, one green and one fused red/green signal (1R1G1F). This is in line with the previously published incidence of this pattern. 2, 3 In most of these 15 cases (n ¼ 13; 7%), the presence of an extensive del(9q) was confirmed by metaphase analyses with both the ES and the D-FISH probes; all of them showed a typical Ph chromosome on conventional cytogenetics. In contrast, two patients (1%) had a normal karyotype with no Ph chromosome being detected; the BCR/ABL gene rearrangements observed in both cases were due to a cryptic insertion of BCR in 9q34, as confirmed by metaphase FISH. These findings, together with those of Wan et al, 1 would support the notion that, in patients in whom a CML is suspected to show an iFISH pattern consistent with an apparent 9q
À and a Ph-negative karyotype, interphase and metaphase FISH investigation of atypical BCR/ABL gene rearrangements should be searched to confirm the presence of cryptic BCR insertion in 9q34. As already mentioned in our previous work, 2 in none of our two cases, neither in the one reported by Wan et al, 1 nuclei carrying a typical MBCR/ABL gene translocation were simultaneously found. These results would further support that this aberrant localization of the BCR/ ABL fused gene may result from an insertion of a chromosome 22 segment comprising the 5 0 side of the BCR 4,5 gene rather than from two sequential translocations, the classical t(9;22) followed by a reverse translocation between the two derivative chromosomes 9 and 22.
6-8 Previous reports have extensively described the genetic abnormalities occurring in CML patients with cryptic insertion of the BCR gene in 9q34. To the best of our knowledge, 25 CML cases carrying this infrequent BCR/ABL gene rearrangement have been reported so far, all of them corresponding to Ph-negative CML patients. We would like to take this opportunity to expand on the clinical characteristics of these infrequent CML patients.
In contrast to the case reported by Wan et al, 1 our two cases as well as most of those reported in the literature 4-24 were adults; both showed splenomegaly and moderate leukocytosis and thrombocytosis (Table 1) . Treatment was carried out with hydroxyurea plus IFN-a in one case and with only hydroxyurea in the other patient, both achieving hematological remission in the absence of a complete cytogenetic response in molecular grounds. Both patients died 6 and 4 years after initial diagnosis, one of them following a transformation into acute leukemia (Table 1) . Interestingly, in this latter patient, transformation into acute leukemia was associated with duplication of the BCR/ABL fusion gene on 9q34 revealed by FISH on metaphase, analogous to the duplication of the Ph þ chromosome in CML cases, giving rise to a new pattern of 1G2F with the ES probe (Figure 1 
